Longevity Atlas · Evidence Intelligence Engine

17,965+ clinical trials indexed — growing every week. Submit an ingredient. We map the evidence into a decision.

Submit an ingredient → AI scans the evidence base → specialist review → citable Intel File in 7 days. East + West coverage. Null results included.

Starting at $799 · 7 business days · scope confirmed before payment

Our primary product

Ingredient Intel File

One ingredient or claim. AI scans, specialist reviews, citable file delivered in 7 days.

  • Executive verdict — Go / No-go with reasoning
  • Human evidence map (RCT count + quality grade)
  • Efficacy boundaries + dosage safety signals
  • Competitive scan + formulation recommendations
  • Supplier audit checklist + primary source appendix
$799
¥4,999 大陆
Scope confirmed before payment · 7 business days
Submit an ingredient →

Sample Intel File · Claim Matrix

This is what's inside every file.

Full sample →
03 · CLAIM MATRIX · Reishi (灵芝)Confidence 72/100
OutcomeDirectionGradeRCTs
Immune modulationPositiveA29
Anti-fatigueModerateB12
Lifespan extensionNeutralD0

EVIDENCE LAYER · scale

55
evidence-graded ingredients
17,965+
clinical trials indexed
East+West
coverage — no Western-only blind spot
PubMed
primary source · ClinicalTrials.gov

Why our Intel Files are different

East + West coverage

Western evidence platforms miss Rhodiola, He Shou Wu, Reishi. We index clinical data for both traditions.

Null results included

We report weak evidence and null results — not just the findings that support a marketing claim.

Primary sources only

Every conclusion links to a live ClinicalTrials.gov or PubMed record. You can verify independently.

Intelligence feed

What's moving in the longevity economy.

All signals →
3 signals
ScienceHIGHLandmark review2023source ↗

The Hallmarks of Aging: An Expanding Universe

WHY IT MATTERS

The field's foundational map — twelve hallmarks now define what aging is and where intervention is possible.

ENTITIESCell Press · López-Otín Lab · Universidad de Oviedo
WATCHWhich of the 12 hallmarks reaches first human trial at scale
CapitalCRITICALIndustryUS / UK2022source ↗

Altos Labs launched with ~$3B for cellular rejuvenation

WHY IT MATTERS

Backed by Bezos and Yuri Milner with Nobel laureate Shinya Yamanaka — the largest private bet that aging is programmable.

ENTITIESAltos Labs · Jeff Bezos · Yuri Milner · Shinya Yamanaka
WATCHFirst cellular reprogramming IND filing; pipeline readouts 2025–2027
CapitalHIGHCapitalSaudi Arabia / Global2024source ↗

Hevolution commits up to $1B/year to healthspan science

WHY IT MATTERS

Saudi-established and now among the world's largest geroscience funders — sovereign capital is entering longevity.

ENTITIESHevolution Foundation · Saudi MiSK Foundation
WATCHGrantee portfolio — which geroscience bets sovereign capital is backing

Get started

Submit your first ingredient.

For supplement brands and formulation teams. Scope confirmed before payment. Intel File in 7 days. Starting at $799.

Submit an ingredient →